Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (12th October 2018)
- Record Type:
- Journal Article
- Title:
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (12th October 2018)
- Main Title:
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
- Authors:
- Qian, Frank
Wang, Shengfeng
Mitchell, Jonathan
McGuffog, Lesley
Barrowdale, Daniel
Leslie, Goska
Oosterwijk, Jan C
Chung, Wendy K
Evans, D Gareth
Engel, Christoph
Kast, Karin
Aalfs, Cora M
Adank, Muriel A
Adlard, Julian
Agnarsson, Bjarni A
Aittomäki, Kristiina
Alducci, Elisa
Andrulis, Irene L
Arun, Banu K
Ausems, Margreet G E M
Azzollini, Jacopo
Barouk-Simonet, Emmanuelle
Barwell, Julian
Belotti, Muriel
Benitez, Javier
Berger, Andreas
Borg, Ake
Bradbury, Angela R
Brunet, Joan
Buys, Saundra S
Caldes, Trinidad
Caligo, Maria A
Campbell, Ian
Caputo, Sandrine M
Chiquette, Jocelyne
Claes, Kathleen B M
Margriet Collée, J
Couch, Fergus J
Coupier, Isabelle
Daly, Mary B
Davidson, Rosemarie
Diez, Orland
Domchek, Susan M
Donaldson, Alan
Dorfling, Cecilia M
Eeles, Ros
Feliubadaló, Lidia
Foretova, Lenka
Fowler, Jeffrey
Friedman, Eitan
Frost, Debra
Ganz, Patricia A
Garber, Judy
Garcia-Barberan, Vanesa
Glendon, Gord
Godwin, Andrew K
Gómez Garcia, Encarna B
Gronwald, Jacek
Hahnen, Eric
Hamann, Ute
Henderson, Alex
Hendricks, Carolyn B
Hopper, John L
Hulick, Peter J
Imyanitov, Evgeny N
Isaacs, Claudine
Izatt, Louise
Izquierdo, Ángel
Jakubowska, Anna
Kaczmarek, Katarzyna
Kang, Eunyoung
Karlan, Beth Y
Kets, Carolien M
Kim, Sung-Won
Kim, Zisun
Kwong, Ava
Laitman, Yael
Lasset, Christine
Hyuk Lee, Min
Won Lee, Jong
Lee, Jihyoun
Lester, Jenny
Lesueur, Fabienne
Loud, Jennifer T
Lubinski, Jan
Mebirouk, Noura
Meijers-Heijboer, Hanne E J
Meindl, Alfons
Miller, Austin
Montagna, Marco
Mooij, Thea M
Morrison, Patrick J
Mouret-Fourme, Emmanuelle
Nathanson, Katherine L
Neuhausen, Susan L
Nevanlinna, Heli
Niederacher, Dieter
Nielsen, Finn C
Nussbaum, Robert L
Offit, Kenneth
Olah, Edith
Ong, Kai-Ren
Ottini, Laura
Park, Sue K
Peterlongo, Paolo
Pfeiler, Georg
Phelan, Catherine M
Poppe, Bruce
Pradhan, Nisha
Radice, Paolo
Ramus, Susan J
Rantala, Johanna
Robson, Mark
Rodriguez, Gustavo C
Schmutzler, Rita K
Hutten Selkirk, Christina G
Shah, Payal D
Simard, Jacques
Singer, Christian F
Sokolowska, Johanna
Stoppa-Lyonnet, Dominique
Sutter, Christian
Yen Tan, Yen
Teixeira, R Manuel
Teo, Soo H
Terry, Mary Beth
Thomassen, Mads
Tischkowitz, Marc
Toland, Amanda E
Tucker, Katherine M
Tung, Nadine
van Asperen, Christi J
van Engelen, Klaartje
van Rensburg, Elizabeth J
Wang-Gohrke, Shan
Wappenschmidt, Barbara
Weitzel, Jeffrey N
Yannoukakos, Drakoulis
Greene, Mark H
Rookus, Matti A
Easton, Douglas F
Chenevix-Trench, Georgia
Antoniou, Antonis C
Goldgar, David E
Olopade, Olufunmilayo I
Rebbeck, Timothy R
Huo, Dezheng
… (more) - Abstract:
- Abstract: Background: BRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2 mutation carriers remains unclear. Methods: We used Mendelian randomization approaches to evaluate the association of height and BMI on breast cancer risk, using data from the Consortium of Investigators of Modifiers of BRCA1/2 with 14 676 BRCA1 and 7912 BRCA2 mutation carriers, including 11 451 cases of breast cancer. We created a height genetic score using 586 height-associated variants and a BMI genetic score using 93 BMI-associated variants. We examined both observed and genetically determined height and BMI with breast cancer risk using weighted Cox models. All statistical tests were two-sided. Results: Observed height was positively associated with breast cancer risk (HR = 1.09 per 10 cm increase, 95% confidence interval [CI] = 1.0 to 1.17; P = 1.17). Height genetic score was positively associated with breast cancer, although this was not statistically significant (per 10 cm increase in genetically predicted height, HR = 1.04, 95% CI = 0.93 to 1.17; P = .47). Observed BMI was inversely associated with breast cancer risk (per 5 kg/m 2 increase, HR = 0.94, 95% CI = 0.90 to 0.98; P = .007). BMI genetic score was also inversely associated with breast cancer risk (per 5 kg/m 2 increase in genetically predicted BMI, HR = 0.87, 95% CI = 0.76 to 0.98; P = .02).Abstract: Background: BRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2 mutation carriers remains unclear. Methods: We used Mendelian randomization approaches to evaluate the association of height and BMI on breast cancer risk, using data from the Consortium of Investigators of Modifiers of BRCA1/2 with 14 676 BRCA1 and 7912 BRCA2 mutation carriers, including 11 451 cases of breast cancer. We created a height genetic score using 586 height-associated variants and a BMI genetic score using 93 BMI-associated variants. We examined both observed and genetically determined height and BMI with breast cancer risk using weighted Cox models. All statistical tests were two-sided. Results: Observed height was positively associated with breast cancer risk (HR = 1.09 per 10 cm increase, 95% confidence interval [CI] = 1.0 to 1.17; P = 1.17). Height genetic score was positively associated with breast cancer, although this was not statistically significant (per 10 cm increase in genetically predicted height, HR = 1.04, 95% CI = 0.93 to 1.17; P = .47). Observed BMI was inversely associated with breast cancer risk (per 5 kg/m 2 increase, HR = 0.94, 95% CI = 0.90 to 0.98; P = .007). BMI genetic score was also inversely associated with breast cancer risk (per 5 kg/m 2 increase in genetically predicted BMI, HR = 0.87, 95% CI = 0.76 to 0.98; P = .02). BMI was primarily associated with premenopausal breast cancer. Conclusion: Height is associated with overall breast cancer and BMI is associated with premenopausal breast cancer in BRCA1/2 mutation carriers. Incorporating height and BMI, particularly genetic score, into risk assessment may improve cancer management. … (more)
- Is Part Of:
- Journal of the National Cancer Institute. Volume 111:Number 4(2019)
- Journal:
- Journal of the National Cancer Institute
- Issue:
- Volume 111:Number 4(2019)
- Issue Display:
- Volume 111, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 111
- Issue:
- 4
- Issue Sort Value:
- 2019-0111-0004-0000
- Page Start:
- 350
- Page End:
- 364
- Publication Date:
- 2018-10-12
- Subjects:
- Cancer -- Periodicals
Cancer -- Research -- Periodicals
616.994 - Journal URLs:
- https://jnci.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/jnci/djy132 ↗
- Languages:
- English
- ISSNs:
- 0027-8874
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4830.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12542.xml